Chih-Hsiu Tu

Dr. Chih-Hsiu Tu

China Medical Univeristy Hospital
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
CTChih-Hsiu Tu
Chih-Hsiu Tu
YCYou-Pen Chiu
You-Pen Chiu
HJHui-Ru Ji
Hui-Ru Ji
CCCheng-Di Chiu
Cheng-Di Chiu
Primary spinal chondrosarcoma (CS) is rare. Only a few previous case reports have included a detailed description of the surgical process used to treat the CS. In addition, a paucity of documentation exists comparing differences in the outcomes between the approaches in en bloc resection. Here, we present a case of CS in the lumbar (L) spine treated with two-stage (anterior and posterior approach) en bloc surgery and analyze the differences between one-stage and two-stage approaches in the treatment of primary lumbar CS. A 30-year-old male patient with an L3 vertebral body CS presented with back pain and lower limb weakness. Lumbar spine magnetic resonance imaging (MRI) showed an L3 vertebral body tumor with cord and root compression. Two-stage surgery comprising posterior total laminectomy and transpedicular screw fixation over L2–L4 in the first stage, with subsequent anterior corpectomy, cage implantation, and anterior lumbar interbody fusion was performed to achieve total tumor removal and stabilization. The patient’s symptoms improved postoperatively, with no recurrence as of the 2-year follow-up. The analysis of previous similar cases showed that two-stage surgery, compared with one-stage surgery, appears to be beneficial in lumbar spine multisegment disease, providing a lower recurrence rate.

2 September 2021 in Medicines
Verified
Journal Article
Open access
PDF file
CCChao-Hsuan Chen
Chao-Hsuan Chen
CTChih-Hsiu Tu
Chih-Hsiu Tu
DCDer-Cherng Chen
Der-Cherng Chen
HHHsiang-Ming Huang
Hsiang-Ming Huang
HCHao-Yu Chuang
Hao-Yu Chuang
HLHan-Chung Lee
Han-Chung Lee
Purpose: This study aims to elucidate the radiological outcome after Cortical bone trajectory (CBT) screw fixation and whether dual-threaded (DT) screws should be used in the fusion surgery. Methods: 159 patients with degenerative lumbar disorder who had undergone midline lumbar inter-body fusion surgery by CBT screw-fixation technique (2014 to 2018). Patient subgroups were based on single-threaded (ST) or DT screw, fixation length, as well as whether fixation involved to sacrum level (S1). Serial dynamic plain films were reviewed and an appearance of a halo phenomenon between screw–bone interfaces was identified as a case of screw loosening. Results: 29 patients (39.7%) in ST group and 10 patients (11.6%) in DT group demonstrated a halo phenomenon (p < 0.0001 ****). After subgrouping with fixation length, the incidence rates of a halo phenomenon in each group were 11.1%:3% (ST-1L vs. DT-1L), 37%:13.8% (ST-2L vs. DT-2L), and 84.2%:23.5% (ST-3L vs. DT-3L). Among the 85 patients with a fixation involved in S1, 26 patients (52%) with single-threaded screw (STS group) and 8 patients (22.8%) with dual-threaded screw (DTS group) demonstrated a halo appearance (p = 0.0078 **). After subgrouping the fixation level, the incidence of a halo appearance in each group was 25%:0% (STS-1L vs. DTS-1L), 40.9%:26.3% (STS-2L vs. DTS-2L), and 87.5%: 30% (STS-3L vs. DTS-3L). Conclusion: Both fixation length and whether fixation involved to S1 contribute to the incidence of screw loosening, the data supports clinical evidence that DT screws had greater fixation strength with an increased fixative stability and lower incidence of screw loosening in CBT screw fixation compared with ST screws. Level of evidence: 2.

7 September 2024 in World Neurosurgery
Verified
Journal Article
Closed access
HLHung-Lin Lin
Hung-Lin Lin
WCWei-Liang Chen
Wei-Liang Chen
CCChun-Chung Chen
Chun-Chung Chen
JGJeng-Hung Guo
Jeng-Hung Guo
YLYu-Fang Liu
Yu-Fang Liu
CTChih-Hsiu Tu
Chih-Hsiu Tu

30 July 2026 in European Spine Journal
Verified
Journal Article
Open access
PDF file
CCChao-Hsuan Chen
Chao-Hsuan Chen
CCChun-Jen Chang
Chun-Jen Chang
HHHsiang-Ming Huang
Hsiang-Ming Huang
HCHao-Yu Chuang
Hao-Yu Chuang
CCCheng-Di Chiu
Cheng-Di Chiu
DBDa-Tian Bau
Da-Tian Bau
Purpose Cement-augmented pedicle screws (CPSCA) and cortical bone trajectory (CBT) screws are used to enhance the fixation strength in osteoporotic bone, but direct comparative clinical evidence remains limited. This study compared 24-month patient-reported outcomes, hospital stay, and complication profiles after CBT versus CPSCA instrumentation in osteoporotic patients undergoing lumbar fixation with interbody fusion. Methods This retrospective cohort study included 134 patients with a bone mineral density T-score < − 2.5 who underwent one- to four-level lumbar fixation with interbody fusion between 2015 and 2021 (CPSCA, n = 63; CBT, n = 71). Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI) scores were assessed preoperatively and at a standardized 24-month clinical assessment, conducted in outpatient clinics or by structured telephone follow-up. Primary multivariable models adjusted for age and number of fusion levels. Expanded sensitivity models additionally incorporated sex, bone mineral density, baseline outcome severity, surgical year, and radiographic follow-up duration where applicable. Complications, reoperations, and minimal clinically important difference (MCID) responder rates were also compared. Results At 24 months, CBT was associated with comparative VAS improvement than CPSCA (adjusted β = 13.39% points, p < 0.001), comparative ODI improvement (adjusted β = 8.53% points, p = 0.003), and shorter hospital stay (adjusted β = −3.00 days, p = 0.020). These associations remained statistically significant in expanded sensitivity analyses. All CBT patients met the predefined MCID thresholds for VAS and ODI, compared with 90.5% and 87.3% of CPSCA patients, respectively; the exact 95% confidence interval for each 100% CBT responder rate was 94.9–100.0%. Recorded perioperative complications occurred in 5 of 63 CPSCA patients (7.9%) and 4 of 71 CBT patients (5.6%; p = 0.734), while reoperation rates were 7.9% and 5.6%, respectively (p = 0.734). Cement leakage occurred only after CPSCA, whereas screw loosening occurred only after CBT. No individual complication differed significantly between groups. Conclusion In this retrospective cohort, CBT instrumentation was associated with comparative 24-month improvement in pain and disability and shorter hospitalization than CPSCA after adjustment for measured covariates. Complication and reoperation rates did not differ statistically, although complication patterns varied between techniques. Because treatment allocation was non-randomised, surgeon and instrumentation effects could not be separated, and the study was underpowered for uncommon adverse events, these findings require cautious interpretation and prospective validation.

10 October 2025 in Medicine
Verified
Journal Article
Open access
CTChih-Hsiu Tu
Chih-Hsiu Tu
WHWei-Lin Hsu
Wei-Lin Hsu
CCChun-Jen Chang
Chun-Jen Chang
YJYu-Chung Juan
Yu-Chung Juan
WHWen-Liang Huang
Wen-Liang Huang
CCChun-Chung Chen
Chun-Chung Chen
Brain metastasis (BM) is associated with poor prognosis and limited therapeutic options. Immunotherapy with dendritic cell (DC) vaccination represents a promising approach by potentially overcoming blood-brain barrier limitations while generating tumor-specific immune responses. This study evaluates the safety and preliminary efficacy of postoperative DC vaccination in patients with surgically resected BMs. We conducted a retrospective analysis of 17 patients (9 women, 8 men; mean age: 56.2 years) with BM from diverse primary cancers who received conventional treatment plus autologous DC vaccination between 2019 and 2022 at a single institution. Following tumor resection, patients received radiotherapy and/or systemic therapy alongside DC vaccination (2 × 10 8 DCs administered subcutaneously) over 6 months. Patients were assessed for adverse events, overall survival (OS), and survival relative to prognostic expectations based on diagnosis-specific graded prognostic assessment (DS-GPA). The median OS was 18 months (95% CI: 9–22), compared to historical median of 14.5 months for surgical resection alone. Patients receiving ≥ 6 vaccine doses demonstrated a median OS of 18 months (95% CI: 9–24) versus17 (95% CI: 3–24) for those receiving < 6 doses (Log-rank test, P = .39). Among 14 patients with available DS-GPA scores, 9 (64.3%) survived longer than their predicted median survival. No vaccine-related serious adverse events were observed, with reactions limited to grade 1 injection site reactions and low-grade fever. This real-world analysis suggests that postoperative DC vaccination for BM is safe and may confer survival benefit compared to historical outcomes. While limited by sample size and retrospective design, our findings warrant further investigation in prospective controlled trials to definitively establish efficacy and optimal integration into multimodal treatment approaches.